Apollo Biopharmaceutics

Apollo Biopharmaceutics is in the development stage, focusing on developing patented drugs to protect brain cells from damage caused by diseases, injuries, and aging. The company’s goals include treating Alzheimer's disease, Parkinson’s disease, strokes caused by brain injuries, and other age-related diseases and conditions. Its main products are based on estrogen compounds, calcitriol or vitamin D-related compounds, and other types of neurosteroids.